Biology of streptococcal capsular polysaccharides

Journal of Applied Microbiology Symposium Supplement

Volumn 83, Issue , 1997, Pages

  Wessels, M R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE;

BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BIOCHEMISTRY; CONFERENCE PAPER; GENETICS; IMMUNOLOGY; NONHUMAN; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A;

EID: 0031413196     PISSN: 02674440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Alberti, S., Ashbaugh, C.D. and Wessels, MLR. (1995) Polymorphism of the group A streptococcal chromosome upstream of the hyaluronic acid capsule synthesis genes. Abstracts of the 95th General Meeting of the American Society Jur Microbiology, 177 (abstract).
2. Ashbaugh, C.D. and Wessels, M.R. (1995a) Identification of a gene similar to ABC transporters near the capsule synthesis region of the group A streptococcal chromosome. In Genetics of Streptococci, Enterococci, and Lactococci ed. Ferretti, J. J., Gilmore, M. S., Klaenhammer, T. R. and Brown, F. pp. 231-235. Basel: Karger.
3. Ashbaugh, C.D. and Wessels, M.R. (1995b) Identification, cloning, and expression of the group A streptococcal guaB gene encoding inosine monophosphate dehydrogenase. Gene 165, 57-60.
4. Baker, C.J. and Barrett, F.F. (1974) Group B streptococcal infection in infants: the importance of the various serotypes. Journal of the American Medical Association 230, 1158-1160.
5. Baker, C.J. and Kasper, D.L. (1976) Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. New England Journal of Medicine 294, 753-
6. 756.
7. Baker, C.J. and Kasper, K.L. (1985) Group B streptococcal vaccines. Reviews of Infectious Diseases 7, 458-467.
8. Baker C.J., Edwards, M.S. and Kasper, D.L. (1978) Immunogenicity of polysaccharides from type III, group B Streptococcus. Journal of Clinical Investigations 61, 1107-1110.
9. Baker, C.J., Edwards, M.S. and Kasper, D.L. (1981) Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 68, 544-549.
10. Bisno, A.L. and Stevens, D.L. (1996) Streptococcal infections of skin and soft tissues. New England Journal of Medicine 334, 240245.
11. Chelsom, J., Halstensen, A., Tore, H. and Hoiby, E.A. (1994) Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 344, 1111-1115.
12. Cleary, P.P., Kaplan, E.L., Handley, J.P. et al. (1992) Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339, 518-521.
13. Crater, D.L. and van de Rijn, I. (1995) Hyaluronic acid synthesis operon (has) expression in group A streptococci. Journal of Biological Chemistry 270, 18452-18458.
14. Crater, 13.L., Dougherty, B.A. and van de Rijn, I. (1995) Molecular characterization of hasC from an operon required for hyaluronic acid synthesis in group A streptococci. Journal of Biological Chemistry 270, 28676-28680.
15. DeAngelis, P.L., Papaconstantinou, J. and Weigel, P.H. (1993a) Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria. Journal of Biological Chemistry 268, 14568-14571.
16. DeAngelis, P.L., Papaconstantinou, J. and Weigel, P.H. (1993b) Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. Journal of Biological Chemistry 268, 19181-19184.
17. DeAngelis, P.I.., Yang, N. and Weigel, P.H. (1995) Molecular cloning of the gene encoding RecF, a DNA repair enzyme, from Streptococcus pygenes. Gene 156, 89-91.
18. DiFabio, J.L., Michon, F., Brisson, J.-R. el al. (1989) Structure of the capsular polysaccharide antigen of type IV group B Streptococcus. Canadian Journal Chemistry 67, 877-882.
19. Dillon, H.C., Khare, S. and Gray, B.M. (1987) Group B streptococcal carriage and disease: a 6-year prospective study. Journal of Pediatrics 110, 31-36.
20. Doctor, A., Harper, M.B. and Fleisher, G.R. (1995) Group A hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics 96, 428-433.
21. Dougherty, B.A. and van de Rijn, I. (1993) Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Journal of Biological Chemistry 10,7118-7124.
22. Dougherty, B.A. and van de Rijn, I. (1994) Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. Journal of Biological Chemistry 269, 169-175.
23. Edwards, M.S., Kasper, D.L., Jennings, HJ., Baker, C.J. and
24. Nicholson-Weller, A. (1982) Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. Journal uf Immunology 128, 1278-1283.
25. Eickhoff, T.C., Klein, J.O., Daly, A.L., Ingall, D. and Finland, M. (1964) Neonatal sepsis and other infections due to group B betahemolytic streptococci. New England Journal of Medicine 271, 1221-1228.
26. Eisenstein, T.K., De Cueninck, B.J., Resavy, D., Shockman, G.D., Carey, R.B. and Swenson, R.M. (1983) Quantitative determination in human sera of vaccine-induced antibody to typespecific polysaccharides of group B streptococci using an enzymelinked immunosorbent assay. Journal of Infectious Diseases 147, 847-856.
27. Parley, M.M., Harvey, R.C., Stull, T. et al. (1993) A populationbased assessment of invasive disease due to group B Streptococcus in nonpregnant adults. New England Journal of Medicine 328, 1807-1811.
28. Fearon, D.T. (1978) Regulation by membrane sialic acid of/HHdependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proceedings of the National Academy of Sciences USA 75, 1971-1975.
29. Fillit, H.M., McCarty, M. and Blake, M. (1986) Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated streptococci. Journal oj Experimental Medicine 164, 762776.
30. Fillit, H.M., Blake, M., MacDonald, C. and McCarty, M. (1988) Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies. Journal uf Experimental Medicine 168, 971-982.
31. Greco, R., DC Martino, L., Donnarumma, G., Conte, M.P., Seganti, L. and Valenti, P. (1995) Invasion of cultured human cells by Streptococcus pyogenes. Research in Microbiology 146, 551-560.
32. Haft, R.F. and Wessels, M.R. (1994) Characterization of CMP-.Vacetylneuraminic acid synthetase of group B Streptococcus. Journal of Bacteriology 176, 7372-7374.
33. Haft, R.H, Wessels, M.R., Mebane, M.F., Conaty, N. and Rubens, C.E. (1996) Characterization of cpsF and its product CMP-.Vacetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in Kl capsular polysaccharide biosynthesis in Escherichia coh. Molecular Microbiology 19, 555-563.
34. Henrichsen, J., Ferrieri, P., Jelinkova, J., Kohler, W. and Maxted, W.R. (1984) Nomenclature of antigens of group B streptococci. International Journal of Systematic Bacteriology 34, 500.
35. Hirst, G.K. (1941) The effect of a polysaccharide splitting enzyme on streptococcal infection. Journal of Experimental Medicine 73, 493-506.
36. Hood, M., Janney, A. and Dameron, G. (1961) Beta hemolytic streptococcus group B associated with problems of perinatal period. American Journal of Obstetrics and Gynecology 82, 809818.
37. Hoogkamp-Korstanje, J.A.A., Gerards, L.J. and Cats, B.P. (1982) Maternal carriage and neonatal acquisition of group B streptococci. Journal of Infectious Diseases 145, 800-803.
38. Jennings, H.J., Rosell, K.-G. and Kasper, D.L. (1980) Structural determination and serology of the native polysaccharide antigen of type-Ill group B Streptococcus. Canadian Journal of Biochemistry 58, 112-120.
39. Jcnnings, HJ., Lugowski, C:. and Kasper, D.I.. (1981) Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry 20, 4SI 1 4518.
40. Jennings, H.J., Kat/enellenbogen, E., Lugowski, C. and Kasper, D.L. (1983a) Structure of the native polysaccharide antigens of type la and type Ih group B Streptococcus. Biochemistry 22, 1258 1263.
41. Jennings, H.J., Rosell, K.-G., Katzenellenbogen, K. and Kasper, D.L. (1983b) Structural determination of the capsular polysaccharide antigen of type II group B streptococci. Journal of Biological Chemistry 258, 1793-1798.
42. Jiang, X.M., Neal, B., Santiago, F., Lee, S.J., Romana, L.K. and Reeves, P.R. (1991) Structure and sequence of the r/b (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Molecular Microbiology 5, 695-713.
43. Johnson, D.R., Stevens, D.L. and Kaplan, E.L. (1992) Epidemiologie analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. Journal of Injections Diseases 166, 374-382.
44. Kapur, V., Reda, K.B. Li, L.-L. Ho, L.-J., Rich, R.R. and Musser, J.M. (1994) Characterization and distribution of insertion sequence 151239 in Streptococcus pyogenes. Gene 150, 135-140.
45. Kasper, D.L., Baker, C.J., Baltimore, R.S., Crabb, J.H., Schiffman, G. and Jennings, H.J. (1979) Immunodeterminant specificity of human immunity to type III group B Streptococcus. Journal oj Experimental Medicine 149, 327 339.
46. Kasper, D.L., Baker, C.J. Galdes, B., Katzenellenbogen, E. and Jennings, H.J. (1983) Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. Journal of Clinical Investigations 72, 260-269.
47. Kasper, D.L., Paoletti, L.C., Wessels, M.R. el al. (1996) Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. Journal of Clinical Investigations 98, 2308-2314.
48. Kass, E.H. and Seastone, C.V. (1944) The role of the mucoid polysaccharide (hyaluronic acid) in the virulence of group A hemolytic streptococci. Journal of Experimental Medicine 79, 319330.
49. Klegerman, M.E., Boyer, K.M., Papierniak, C.K., Levine, L. and Gotoff, S.P. (1984) Type-specific capsular antigen is associated with virulence in late-onset group B streptococcal type III disease. Injection and Immunity 44, 124-129.
50. Kogan, G., Uhrin, D., Brisson, J.-R. et al. (1994) Structure of the type VI group B Streptococcus capsular polysaccharide determined by high resolution NMR spectroscopy. Journal of Carbohydrate Chemistry 13, 1071-1078.
51. Kogan, G., Brisson, J.-R., Kasper, D.L., von Hunolstein, C., Orefici, G. and Jennings, H.J. (1995) Structure of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydrate Research 277, 1-9.
52. Kogan, G., Uhrin, D., Brisson, J.-R. et al. (1996) Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. Journal of Biological Chemistry 271, 8786-8790.
53. Lancefield, R.C. (1962) Current knowledge of the type specific M antigens of group A streptococci. Journal of Immunology 89, 307313.
54. Lancefield, R.C., McCarty, M. and Everly, W.N. (1975) Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. Journal of Experimental Medicine 142, 165 179.
55. LaPenta, 1)., Rubens, C, Chi, K. and Clean, P.P. (1994) Group A streptococci efficiently invade human respiratory epithelial cells. Proceedings of the National Academy of Sciences L'S.l 91, 12115-
56. 12119.
57. Marcon, M.J., Hribar, M.M, Hosier, D.M. el al. (1988) Occurrence of mucoid M-18 Streptococcus pyogenes in a central Ohio pédiatrie population. Journal of Clinical M icrohiology 26, 1539-1542.
58. Marques, M.B., Kasper, D.L., Pangburn, M.K. and Wessels, M.R. (1992) Prevention of C3 deposition is a virulence mechanism of type III group B Streptococcus capsular polysaccharide. Injection and Immunity 60, 3986-3993.
59. Massell, B., Chute, C., Walker, A. and Kurland, G. (1988) Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. New England Journal of Medicine 318, 280-286.
60. Musser, J.M., Hauser, A.R., Kim, M.H., Schlievert, P.M., Nelson, K. and Selander, R.K. (1991) Streptococcus pyogenes causing toxic shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proceedings of the National Academy of Sciences USA 88, 2668-2672.
61. Pangburn, M.K. and Muller-Eberhard, H.J. (1978) Complement C3 convertase: cell surface restriction of \H control and generation of restriction on neuraminidase treated cells. Proceedings of the National Academy of Sciences USA 75, 2416-2420.
62. Paoletti, L.C., Wessels, M.R., Michon, F., DiFabio, J., Jennings, H.J. and Kasper, D.L. (1992) Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Injection and Immunity 60, 4009-4014.
63. Paoletti, L.C., Wessels, M.R., Rodewald, A.K., Shroff, A.A., Jennings, H.J. and Kasper, D.L. (1994) Neonatal mouse protection against infection with multiple group B streptococcal serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Injection and Immunity 62, 3236-3243.
64. Rubens, C.E., Wessels, M.R., Heggen, L.M. and Kasper, D.L. (1987) Transposon mutagenesis of group B streptococcal type III capsular polysaccharide: correlation of capsule expression with virulence. Proceedings of the National Academy of Sciences USA 84, 7208-7212.
65. Rubens, C.E., Heggen, L.M. and Kuypers, J.M. (1989) IS86I, a group B streptococcal insertion sequence related to IS/50 and ISJ of Escherichia coli. Journal oj Bacteriology 171, 5531-5535.
66. Rubens, C.E., Heggen, L.M., Haft, R.F. and Wessels, M.R. (1993) Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Molecular Microbiology 8, 843-855.
67. Rubens, C.E., Haft, R.F. and Wessels, M.R. (1995) Characterization of the capsular polysaccharide genes of group B streptococci. In Genetics of Streptococci, Enterucocci, and Lactucocci ed. Ferretti, J. J., Gilmore, M. S., Klaenhammer, T. R. and Brown, F. pp. 237244. Basel: Karger.
68. Sandson, J., Hamerman, D., Janic, R. and Rojkind, M. (1968) Immunologie and chemical similarities between the streptococcus
69. and human connective tissue. Transactions of the Association of American Physicians 81, 249-257.
70. Schräger, H.M., Rheinwald, J.G. and Wessels, M.R. (1996) Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. Journal of Clinical Investigations 98, 1954-1958.
71. Schuchat, A. and Wenger, J. (1994) Epidemiology of group B streptococcal disease. Epidemiology Reviews 16, 374-402.
72. Schwanz, B., Schuchat, A., Oxtoby, M.J., Cochi, S.L., Hightower, A. and Broome, C.V. (1991) Invasive group B streptococcal disease in adults, a population-based study in metropolitan Atlanta. Journal of the American Medical Association 266, 1112-1114.
73. Stevens, D.L. (1992) Invasive group A streptococcus infections. Clinical Infectious Diseases 14, 2-11.
74. Stevens, D.I,., Tanner, M.H., Winship, J. et al. (1989) Severe group A streptococcal infections associated with a toxic shocklike syndrome and scarlet fever toxin. A. New England Journal of Medicine 321, 1-8.
75. Talkington, D.F., Scwartz, B., Black, CM. et al. (1993) Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infection and Immunity 61, 3369-3374.
76. Veasy, L.G., Wiedmeier, S.E., Orsmond, G.S. et al. (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. New England Journal of Medicine 316, 12981315.
77. Wenger, J.D., Hightower, A.W., Facklam, R.R., Gaventa, S. and Broome, C.V. (1990) Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. Journal of Infectious Diseases 162, 1316-1323.
78. Wessels, M.R. and Bronze, M.S. (1994) Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proceedings of the National Academy of Sciences USA 91, 12238-12242.
79. Wessels, M.R., Munoz, A. and Kasper, D.L. (1987a) A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide. Proceedings of the National Academy of Sciences USA 84, 9170-9174.
80. Wessels, M.R., Pozsgay, V., Kasper, D.L. and Jennings, HJ. (1987b) Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. Journal of Biological Chemistry 262, 8262-8267.
81. Wessels, M.R., Rubens, C.E., Benedi, V.-J. and Kasper, D.L. (1989) Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proceedings of the National Academy of Sciences USA 86, 8983-8987.
82. Wessels, M.R., Paoletti, L.C., Kasper, D.L. et al. (1990) Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. Journal of Clinical Investigâtions 86, 1428-1433.
83. Wessels, M.R., DiFabio, J.L., Benedi, V.-J. et al. (1991a) Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. fournal of Binlogical Chemistry 266, 6714-6719.
84. Wessels, M.R., Moses, A.E., Goldberg, J.B. and DiCesare, T.J. (1991b) Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proceedings of the National Academy of Sciences USA 88, 8317-8321.
85. Wessels, M.R., Haft, R.F., Heggen, L.M. and Rubens, C.E. (1992) Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infection and Immunity 60, 392 400.
86. Wessels, M.R., Paoletti, L.C., Rodewald, A.K. et al. (1993) Stimulation of protective antibodies against type la and Ib group B streptococci by a type la polysaccharide-tetanus toxoid conjugate vaccine. Injection and Immunity 61, 4760-J766.
87. Wessels, MR., Goldbcrg, J.B., Moses, A.E. and DiCesare, T.J. (1994) Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infection and Immunity 62, 433-441.
88. Wessels, M.R., Paoletti, L.C., Pinel, J. and Kasper, D.L. (1995) Immunogenicity and protective activity in animals of a group B Streptococcus type V polysaccharide-tetanus toxoid conjugate vaccine. Journal of Infectious Diseases 171, 879-884.
89. Westlake, R., Graham, T. and Edwards, K. (1990) An outbreak of acute rheumatic fever in Tennessee. Pédiatrie Injections Diseuse Journal 9, 97-100.
90. Wilkinson, H.W. and Eagon, R.G. (1971) Type-specific antigens of group B type Ic streptococci. Infection anil Immunity 4, 596- 604.
91. Wilson, A.T. (1959) The relative importance of the capsule and the M antigen in determining colony form of group A streptococci. Journal of Experimental Medicine 109, 257-270.
92. Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. Journal of the American Medicine Association 269, 390-391.